<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font16 { font-size : 16; } .font17 { font-size : 17; } .font22 { font-size : 22; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font30">influenza </span>
   <span class="font22">virus </span>
   <span class="font17">viral </span>
   <span class="font16">viruses </span>
   <span class="font15">resistance </span>
   <span class="font14">baloxavir </span>
   <span class="font14">clinical </span>
   <span class="font14">RNA </span>
   <span class="font13">antiviral </span>
   <span class="font13">inhibitor </span>
   <span class="font13">human </span>
   <span class="font13">treatment </span>
   <span class="font13">drug </span>
   <span class="font13">{border-style </span>
   <span class="font13">marboxil </span>
   <span class="font12">disease </span>
   <span class="font12">px;} </span>
   <span class="font12">#ffffff;} </span>
   <span class="font12">efficacy </span>
   <span class="font12">high </span>
   <span class="font12">activity </span>
   <span class="font12">endonuclease </span>
   <span class="font12">mutations </span>
   <span class="font12">replication </span>
   <span class="font12">Agents </span>
   <span class="font12">Infect </span>
   <span class="font12">Res </span>
   <span class="font12">polymerase </span>
   <span class="font12">resistant </span>
   <span class="font12">respiratory </span>
   <span class="font12">IAV </span>
   <span class="font12">approved </span>
   <span class="font12">inhibitors </span>
   <span class="font12">risk </span>
   <span class="font11">oral </span>
   <span class="font11">neuraminidase </span>
   <span class="font11">ribonucleoside </span>
   <span class="font11">use </span>
   <span class="font11">Chemother </span>
   <span class="font11">Dis </span>
   <span class="font11">However, </span>
   <span class="font11">barrier </span>
   <span class="font11">circulating </span>
   <span class="font11">development </span>
   <span class="font11">escape </span>
   <span class="font11">infection </span>
   <span class="font11">seasonal </span>
   <span class="font11">therapeutics </span>
   <span class="font11">uncomplicated </span>
   <span class="font11">analog </span>
   <span class="font11">antibody </span>
   <span class="font11">mitochondrial </span>
   <span class="font11">oseltamivir </span>
   <span class="font11">safety </span>
   <span class="font11">therapeutic </span>
   <span class="font11">Med </span>
   <span class="font11">adults </span>
   <span class="font11">cell </span>
   <span class="font11">highly </span>
   <span class="font11">low </span>
   <span class="font11">neutralizing </span>
   <span class="font11">novel </span>
   <span class="font11">px; </span>
   <span class="font11">strains </span>
   <span class="font11">vitro </span>
   <span class="font11">{font-family </span>
   <span class="font11">A(HN) </span>
   <span class="font11">Influenza </span>
   <span class="font11">NAIs </span>
   <span class="font11">amantadine </span>
   <span class="font11">antibodies </span>
   <span class="font11">currently </span>
   <span class="font11">font-size </span>
   <span class="font11">group </span>
   <span class="font11">influenza: </span>
   <span class="font11">major </span>
   <span class="font11">pathogenic </span>
   <span class="font11">patients </span>
   <span class="font11">pediatric </span>
   <span class="font11">revealed </span>
   <span class="font11">studies </span>
   <span class="font11">target </span>
   <span class="font11">vaccine </span>
   <span class="font10">(Fig </span>
   <span class="font10">IBV </span>
   <span class="font10">Sci </span>
   <span class="font10">United </span>
   <span class="font10">acid </span>
   <span class="font10">airway </span>
   <span class="font10">approximately </span>
   <span class="font10">broad-spectrum </span>
   <span class="font10">class </span>
   <span class="font10">dose </span>
   <span class="font10">double; </span>
   <span class="font10">effects </span>
   <span class="font10">emerged </span>
   <span class="font10">frequency </span>
   <span class="font10">genetic </span>
   <span class="font10">groups </span>
   <span class="font10">host </span>
   <span class="font10">host-directed </span>
   <span class="font10">lower </span>
   <span class="font10">new </span>
   <span class="font10">next-generation </span>
   <span class="font10">orally </span>
   <span class="font10">patient </span>
   <span class="font10">primary </span>
   <span class="font10">protein </span>
   <span class="font10">resulting </span>
   <span class="font10">study </span>
   <span class="font10">susceptibility </span>
   <span class="font10">trial </span>
   <span class="font10">viruses, </span>
   <span class="font10">(PO) </span>
   <span class="font10">Acad </span>
   <span class="font10">EIDD- </span>
   <span class="font10">Elsevier </span>
   <span class="font10">RdRP </span>
   <span class="font10">States </span>
   <span class="font10">acute </span>
   <span class="font10">administration </span>
   <span class="font10">adverse </span>
   <span class="font10">animal </span>
   <span class="font10">avian </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">broadly </span>
   <span class="font10">cap-dependent </span>
   <span class="font10">cells </span>
   <span class="font10">characterization </span>
   <span class="font10">compound </span>
   <span class="font10">controlled </span>
   <span class="font10">different </span>
   <span class="font10">drugs </span>
   <span class="font10">experimental </span>
   <span class="font10">fitness </span>
   <span class="font10">inhibition </span>
   <span class="font10">lethal </span>
   <span class="font10">marboxil, </span>
   <span class="font10">mechanisms </span>
   <span class="font10">mutation </span>
   <span class="font10">phase </span>
   <span class="font10">population </span>
   <span class="font10">potential </span>
   <span class="font10">random </span>
   <span class="font10">severe </span>
   <span class="font10">signature </span>
   <span class="font10">solid; </span>
   <span class="font10">substitutions </span>
   <span class="font10">syncytial </span>
   <span class="font10">systematic </span>
   <span class="font10">tract </span>
   <span class="font10">transition </span>
   <span class="font10">upper </span>
   <span class="font10">vivo </span>
   <span class="font10">years </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">COVID- </span>
   <span class="font10">Ebola </span>
   <span class="font10">IAVs </span>
   <span class="font10">Natl </span>
   <span class="font10">Virol </span>
   <span class="font10">addition </span>
   <span class="font10">analogs </span>
   <span class="font10">antivirals </span>
   <span class="font10">available </span>
   <span class="font10">bioavailable </span>
   <span class="font10">bold </span>
   <span class="font10">broad </span>
   <span class="font10">centre </span>
   <span class="font10">concerns </span>
   <span class="font10">conserved </span>
   <span class="font10">courier; </span>
   <span class="font10">current </span>
   <span class="font10">data </span>
   <span class="font10">demonstrated </span>
   <span class="font10">efficacious </span>
   <span class="font10">em; </span>
   <span class="font10">epithelium </span>
   <span class="font10">favipiravir </span>
   <span class="font10">free </span>
   <span class="font10">function </span>
   <span class="font10">harboring </span>
   <span class="font10">health </span>
   <span class="font10">hepatitis </span>
   <span class="font10">including </span>
   <span class="font10">increased </span>
   <span class="font10">infection, </span>
   <span class="font10">infections </span>
   <span class="font10">inhibits </span>
   <span class="font10">instance, </span>
   <span class="font10">load </span>
   <span class="font10">monoclonal </span>
   <span class="font10">mutagenesis </span>
   <span class="font10">older </span>
   <span class="font10">pandemic </span>
   <span class="font10">pimodivir </span>
   <span class="font10">pregnant </span>
   <span class="font10">preventing </span>
   <span class="font10">pt;} </span>
   <span class="font10">public </span>
   <span class="font10">recommended </span>
   <span class="font10">reduced </span>
   <span class="font10">reducing </span>
   <span class="font10">research </span>
   <span class="font10">residues </span>
   <span class="font10">resource </span>
   <span class="font10">review </span>
   <span class="font10">signs. </span>
   <span class="font10">subunit </span>
   <span class="font10">targeting </span>
   <span class="font10">targets </span>
   <span class="font10">typically </span>
   <span class="font10">variants </span>
   <span class="font10">year </span>
  </p>
 </body>
</html>
